The "knock-off" versions of semaglutide emerged to fill a void when Wegovy was on the FDA's drug shortage list, and it led to "the lower-than-planned penetration of branded GLP-1s", as the CFO ...

Prices are falling for the popular obesity treatments Wegovy and Zepbound, but steady access to the drugs remains challenging ...

Health Canada has issued a recall notice for compounded drugs containing semaglutide, which is a key component in popular ...

Based on this, the percentage of HIMS's income from compounded GLP-1s in Q4 2024 can be calculated as follows: Estimated Q4 2024 GLP-1 Revenue: $127.0 million Total Q4 2024 Revenue: $481.1 million ...

Membership costs vary based on the type of drug you’re prescribed and how often you’re billed: Compounded semaglutide: $199 per month ($2,388 total) for a 12-month membership, paid in full ...

Peptide agonists of the glucagon-like peptide-1 receptor (GLP-1R) have revolutionized diabetes therapy, but their use has been limited because they require injection. Herein, we describe the discovery ...